Financial statements Biosynthesis

Balance sheet of Biosynthesis

Company age:
Age:
10 y. 1 m.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOSYNTHESIS

Year
2018
2019
2020
2021
2022
2023
Total assets 26 922,05 26 922,05 29 455,07 31 141,67 68 379,32 54 971,12
A. Fixed assets 14 799,93 14 799,93 14 799,93 14 799,93 7 399,89 7 399,89
B. Current assets 12 122,12 12 122,12 14 655,14 16 341,74 60 979,43 47 571,23
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 26 922,05 26 922,05 29 455,07 31 141,67 68 379,32 54 971,12
A. Equity 26 282,55 26 282,55 29 031,55 29 816,55 56 184,97 45 406,30
B. Liabilities and provisions for liabilities 639,50 639,50 423,52 1 325,12 12 194,35 9 564,82
I. Long-term liabilities - - - 0,00 0,00 0,00
II. Short-term liabilities 639,50 639,50 423,52 1 325,12 12 194,35 9 564,82
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.